DUBLIN, June 20, 2022 /PRNewswire/ -- The "Sepsis Diagnostics Global Markets by Assay, by Cause, by Product, by Lab, and by Place. With Executive and Consultant Guides and Sepsis Market Analysis and Forecasts 2022 - 2026" report has been added to ResearchAndMarkets.com's offering.
The report forecasts the market size out to 2026. Growth is coming from the basic factors but the COVID-19 pandemic has changed to the market landscape now and for the foreseeable future. Over 45 million people a year suffer from sepsis and there is no definitive diagnosis. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID infections. Understand the different drivers of this huge global diagnostic market and find where the opportunities lie. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks.
The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities. The Cytokine Storm - Diagnostic Needs
The Cytokine Storm - COVID and Other Situations
Impact of COVID on Sepsis Prevalence Presymptom Health Developing Test for Sepsis Personalized Medicine in Sepsis SpeeDx Developing Respiratory Virus Host-Response Test Sepset Biosciences Using COVID-19 Patient Samples to Validate Sepsis Test DNAe Developing POC Sequencing for Sepsis NGS technique offers quick, accurate diagnosis of Sepsis Portable device diagnoses sepsis faster Ontera and QuantuMDx Collaborate on Sepsis Dx Blood Test Accurately Predicts Sepsis Severity BARDA/ HHS to support Cytovale rapid test Sepsis found to fit into 4 Subtypes GenMark Diagnostics Receives Clearance for Blood Panel New Test Could Diagnose Sepsis Faster Curetis' Unyvero Cartridges Receive Approvals
Experimental 2.5-minute Sepsis Test Discovered Septec Team Working on 15 Minute Sepsis Diagnosis Profiles of Key Companies
Becton, Dickinson and Company
Roche Molecular Diagnostics Players in a Dynamic Market
Pharmaceutical/Reagent Supplier
Public National/regional lab
The Cost Curve Shrinks the Market
Adoption Lag and Cost Control
Diagnostic Technology Development
The Multiplex Opportunity
Shifting Role of Physicians in Diagnosis
Diagnostics Moves Out of the Lab
Biomarkers and Algorithms
Rapid Testing Changing Medical Practice For more information about this report visit https://www.researchandmarkets.com/r/y22t52
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716